Personalized medicine offers tremendous hope for patients. This change in focus to specialty treatments for highly defined patient populations also requires a change in how research works, customized just as specifically as the treatments it is designed to test.
IQVIA combines deep therapeutic and scientific knowledge with unmatched experience in clinical trial design and execution. Using the IQVIA CORE we can integrate data, analytics, and technology around the specific requirements of your trial. So we can anticipated challenges, ask the right questions and help you
Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Identify the best performing sites for your trial in less time with new machine learning and predictive modeling methods.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Bring trials directly to patients to decrease costs, increase quality and improve access.